Information Journal Paper
APA:
Copy. (2020). Arguments in favour of remdesivir for treating SARS-CoV-2 infections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 55(4), 0-0. SID. https://sid.ir/paper/696814/en
Vancouver:
Copy. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS[Internet]. 2020;55(4):0-0. Available from: https://sid.ir/paper/696814/en
IEEE:
Copy, “Arguments in favour of remdesivir for treating SARS-CoV-2 infections,” INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 55, no. 4, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/696814/en